# Study of TDM-180935 in Atopic Dermatitis Patients

> **NCT06363461** · PHASE2 · COMPLETED · sponsor: **Technoderma Medicines Inc.** · enrollment: 24 (actual)

## Conditions studied

- Atopic Dermatitis

## Interventions

- **DRUG:** TDM-180935 topical ointment 1.0%
- **DRUG:** TDM-180935 topical ointment 2.0%
- **DRUG:** TDM-180935 topical vehicle ointment 1
- **DRUG:** TDM-180935 topical vehicle ointment 2

## Key facts

- **NCT ID:** NCT06363461
- **Lead sponsor:** Technoderma Medicines Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-04-13
- **Primary completion:** 2025-03-08
- **Final completion:** 2025-04-08
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2025-04-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06363461

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06363461, "Study of TDM-180935 in Atopic Dermatitis Patients". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT06363461. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*